Catheterization Lab Equipment in Utah

Route 92 Medical is a neurovascular intervention medical device company headquartered in San Mateo, California, specializing in endovascular thrombectomy solutions for acute ischemic stroke treatment. The company develops proprietary catheter systems and delivery technologies designed to overcome critical limitations in current neurointervention approaches, including poor navigability through tortuous anatomy, prolonged procedure times, and high failure rates in reaching target lesions. Route 92 Medical's product portfolio includes the FreeClimb Catheter Systems (FreeClimb 54, 70, and 88) powered by Tenzing delivery technology, and the HiPoint Reperfusion System featuring the Monopoint Approach for streamlined super-bore aspiration delivery. These integrated solutions serve interventionalist clinicians and hospitals performing neurovascular procedures, offering comprehensive platforms that eliminate the need for device workarounds and enhance procedural efficiency and clinical outcomes in stroke intervention.

ATL Technology LLC is a vertically integrated medical device design, development, and manufacturing company headquartered in Springville, Utah, with facilities in Maple Grove, Minnesota, and international operations in Costa Rica, China, Taiwan, and the United Kingdom. The company provides end-to-end solutions from concept through market commercialization, including design and development, prototyping, regulatory compliance, testing, and high-volume manufacturing of finished medical devices and complex sub-assemblies. Core manufacturing capabilities include catheter extrusion, braided shaft manufacturing, injection molding, wire and cable extrusion, surface-mount technology (SMT), printed circuit board assembly (PCBA), full automation, packaging, and sterilization. The company serves OEM device developers across multiple specialties including minimally invasive surgery, endoscopy, electrosurgery, electrophysiology (cardiac ablation and mapping), patient monitoring, and medical wearables. ATL specializes in camera-based visualization systems for minimally invasive procedures, featuring proprietary Chip-On-Tip® technology that integrates compact cameras into device components. The company offers the PREVOYANCE® Camera Assembly as a pre-designed device development accelerator enabling rapid integration into next-generation medical imaging platforms. Additional specializations include Ultra High-Density Interconnect solutions for electrophysiology catheters, energy-driven minimally invasive surgical device components, and custom interconnect and flex assembly solutions for complex catheter and wearable applications. The company employs an engineer-to-engineer partnership approach with medical device OEMs to accelerate product development while maintaining quality and manufacturability standards.

Scientia Vascular is a medical device company specializing in neurovascular and peripheral vascular access technologies for interventional procedures. Founded in 2007 and based in West Valley City, Utah, the company develops precision-engineered guidewires and catheters using proprietary microfabrication techniques. The company's core innovation involves creating nitinol hypotube devices with patented microfeatures—rings and interconnected beams—that enable superior flexibility, control, and torque transmission compared to conventional braid-and-coil designs. Key FDA-cleared products include the Aristotle® 24 guidewire and Plato 17 and Socrates 38 catheters, designed for reliable access to diseased brain areas and improved therapy delivery for stroke and other cerebrovascular conditions. With ~86 employees and $64M in funding, Scientia focuses on enhancing physician control and treatment outcomes in complex neurovascular interventions through next-generation access system design.

Diacor manufactures precision patient positioning and transfer systems for image-guided radiation oncology and hybrid operating rooms. Founded in 1983, the company specializes in the Zephyr hoverboard technology platform, which enables submillimeter-accurate patient transfer across multiple imaging modalities (MRI, CT, PET/CT, angiography) while maintaining positional integrity. Zephyr systems are designed for Image-Guided Brachytherapy (IGBT), Image-Guided Radiotherapy (IGRT), intraoperative MRI (iMRI), interventional cardiovascular MRI (iCMR), and hybrid OR procedures. The company works closely with radiation therapists, oncologists, and interventional cardiologists to develop solutions that streamline clinical workflows, reduce patient transfer time, and enhance treatment accuracy. With hundreds of global installations in premier cancer centers and hybrid ORs, Diacor provides unparalleled product support and distributor partnerships worldwide.

Merit Medical Systems, Inc. is a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures. Founded in 1987 and headquartered in South Jordan, Utah, the company employs approximately 7,000 people worldwide and serves hospitals and physicians across the globe. Merit specializes in devices for cardiology, radiology, oncology, critical care, and endoscopy applications. The product portfolio includes catheters, guide wires, balloons, inflation devices, syringes, needles, stents, biopsy tools, drainage systems, embolics and delivery systems, access devices, and monitoring equipment. Merit serves multiple clinical specialties including interventional cardiology, interventional radiology, gastroenterology, critical care, electrophysiology, nephrology, pulmonology, breast surgery, and interventional oncology. The company offers procedural solutions for cardiac catheterization, dialysis access, biopsy procedures, embolotherapy, stricture management, spine interventions, and structural heart applications. Merit operates globally with manufacturing and distribution capabilities supporting complex interventional procedures. The company provides clinician education through Merit's Think Education program and maintains regulatory compliance appropriate for disposable medical devices in the United States and international markets.

enableCV, LLC is an independent cardiac surgery device company focused on advancing minimally invasive and open-heart surgical procedures. The company develops innovative medical devices designed to provide continuous blood flow during cardiopulmonary bypass and enable next-generation cardiac surgery techniques. EnableCV's product portfolio includes the IntraClude intra-aortic occlusion device for minimally invasive cardiac procedures, the ProPlege peripheral retrograde cardioplegia device for coronary sinus occlusion and cardioplegia delivery, the QuickDraw Plus femoral venous cannula for blood drainage during bypass, and arterial cannulae (OptiSite and EZ Glide) for short-term perfusion. The company leverages deep expertise developed through its heritage with Edwards Lifesciences and collaborates with a preeminent medical advisory board to expand its portfolio. All devices are FDA-regulated and restricted to sale by or on the order of a physician. EnableCV serves cardiac surgeons and cardiothoracic surgical centers requiring specialized bypass and cardioplegia management solutions.

Transit Scientific, LLC manufactures minimally invasive vascular intervention devices focused on peripheral vasculature and dialysis access applications. The company's primary product platform is the XO Score® Sheath Platform, an FDA 510(k) and CE Mark cleared device designed for use with percutaneous transluminal angioplasty (PTA) balloons to facilitate dilation and vessel wall apposition in treating stenotic lesions across multiple vascular territories. Indicated applications include iliac, femoral, ilio-femoral, popliteal, infra-popliteal, and renal arteries, as well as obstructive lesions in native or synthetic arteriovenous dialysis fistulae. The company also offers the XO Cross® Catheter Platform, similarly FDA 510(k) and CE Mark cleared, designed to guide and support guidewires during peripheral vascular access, enable wire exchanges, and serve as a delivery conduit for saline solutions or diagnostic contrast agents. The XO Cath microcatheter line extends the portfolio for controlled and selective infusion of diagnostic, embolic, or therapeutic materials into peripheral vessels, with demonstrated clinical use in transradial embolic delivery procedures. All products are cleared for peripheral vascular intervention but explicitly contraindicated for coronary and neuro-vascular applications. Transit Scientific positions itself within the interventional cardiology and peripheral vascular device sector, targeting interventionalists and vascular surgeons managing stenotic disease and dialysis access complications.

Zien Medical Technologies is a medical device integrator and contract manufacturer specializing in product development, design control, regulatory compliance, and manufacturing for startups and established companies. The company offers end-to-end capabilities spanning design, engineering, quality systems, manufacturing, assembly, laser cutting, nitinol processing, contract packaging, sterilization, and regulatory affairs. Zien has participated in developing devices across interventional radiology, cardiac surgery, neurosurgery, gynecological, gastrointestinal, acute care, and general surgery specialties. The company acts as manufacturer of record, helping clients navigate FDA 21 CFR Part 11 and ISO 13485 certification requirements to achieve global regulatory clearance. Zien's integrated infrastructure enables startups to accelerate product launches with up to 70% lower development costs and 12–24 months reduction in time to market, eliminating the need for clients to build proprietary facilities or hire full internal teams. The company manufactures and distributes its own branded product lines including SAM Medical (surgical devices), MorTan, and Syntervention products, each supported by digital instructions for use (eIFU). Services include design control and regulatory services, business and development planning, process development and validation, and contract sterilization and packaging operations.

Biomerics is a leading vertically integrated contract development and manufacturing organization (CDMO) specializing in interventional medical devices and components. Established in 1994 and headquartered in Salt Lake City, Utah, the company operates 12 facilities globally across the United States, Ireland, Costa Rica, and the Dominican Republic, employing over 3,200 professionals. The company ranks among the Top 10 interventional CDMOs worldwide and serves 20 of the top 35 medical device OEMs. Biomerics provides end-to-end manufacturing capabilities including design engineering, materials compounding, complex extrusion, micromachining, micro metals processing, and finished device assembly. Core competencies span structural heart, electrophysiology, robotic surgery, endoscopy, and image-guided intervention platforms. The company offers specialized services including polymer and metal fabrication, device packaging, sterilization, and technology transfer. All operations maintain ISO 13485:2016 certification and FDA compliance, with dedicated Centers of Excellence in advanced materials, complex extrusion, and micromachining to support rapid innovation and market delivery.